Orphelia Pharma
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| TEMOkids Study : A Phase I Pediatric Study for KIMOZO, Oral Suspension of Temozolomide (NCT04610736) | Orphelia Pharma | 2021-03-16 |
| Bioequivalence Study Between Temozolomide Oral Suspension (Ped-TMZ) and Temodal® Capsules (NCT04467346) | Orphelia Pharma | 2020-09-25 |
Track Orphelia Pharma automatically
Every clearance here is in the API, with alerts when new ones post.